[HTML][HTML] Autoimmunity as the comet tail of COVID-19 pandemic

R Talotta, E Robertson - World Journal of Clinical Cases, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can give rise to
different clinical manifestations that are directly related to viral tissue damage or indirectly …

COVID-19 in immunosuppressed children

E Nicastro, L Verdoni, LR Bettini, G Zuin… - Frontiers in …, 2021 - frontiersin.org
Following the spread of the SARS-CoV-2 infection and coronavirus disease 2019 (COVID-
19) to a global pandemic, concerns have arisen for the disease impact in at-risk populations …

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti …

X Michelena, H Borrell, M Lopez-Corbeto… - Seminars in arthritis and …, 2020 - Elsevier
Objectives To investigate the incidence of COVID-19 in a cohort of adult and paediatric
patients with rheumatic diseases receiving targeted biologic and synthetic disease …

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE … - Annals of the …, 2021 - ard.bmj.com
Objectives There is little known about the impact of SARS-CoV-2 on patients with
inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined …

Risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases

J Bachiller-Corral, A Boteanu… - The Journal of …, 2021 - jrheum.org
Objective. To describe the cohort of patients with inflammatory rheumatic diseases (IRD)
hospitalized due to SARS-CoV-2 infection in the Ramón y Cajal Hospital, and to determine …

Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective

A Mardi, S Meidaninikjeh, S Nikfarjam… - Viral …, 2021 - liebertpub.com
The newfound coronavirus disease 2019 (COVID-19), initiated by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an international public health concern …

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic

F Haslak, M Yildiz, A Adrovic, S Sahin, O Koker… - Rheumatology …, 2020 - Springer
Concerns regarding the comorbidity as a significant risk factor for Coronavirus Disease-
2019 (COVID-19), gave rise to an urgent need for studies evaluating patients with chronic …

A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management

N Bansal, C Pasricha, P Kumari, S Jangra, R Kaur… - Autoimmunity …, 2023 - Elsevier
Rheumatoid Arthritis (RA) is a progressive autoimmune disease. It is among the most
widespread chronic illnesses in children, with an annual incidence of 1.6 to 23 new …

COVID-19 management in the pediatric age: consensus document of the COVID-19 working group in paediatrics of the Emilia-Romagna region (RE-CO-Ped), Italy

S Esposito, F Marchetti, M Lanari, F Caramelli… - International Journal of …, 2021 - mdpi.com
Since December 2019, coronavirus disease (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread, becoming the first pandemic of …

Implications of COVID-19 in pediatric rheumatology

ED Batu, S Özen - Rheumatology International, 2020 - Springer
Abstract COVID-19 (coronavirus disease 2019) pandemic caused by SARS-CoV-2, is a
global public health issue threatening millions of lives worldwide. Although the infection is …